The Relationship Between Epicardial Fat and Indices of Obesity and the Metabolic Syndrome: A Systematic Review and Meta-Analysis
Publication: Metabolic Syndrome and Related Disorders
Volume 12, Issue Number 1
Abstract
Epicardial fat (epicardial adipose tissue, EAT) has been implicated in the pathogenesis of coronary artery disease (CAD). The objective of this study was to examine the relationship between EAT and generalized obesity, central or visceral adipose tissue (VAT), and the components of the metabolic syndrome—systolic blood pressure (SBP), triglycerides (TGs), high-density lipoprotein cholesterol (HDL-C), and fasting blood glucose (FBG)—that are linked to CAD. A systematic review of the literature, following meta-analysis guidelines, was conducted until May, 2013, using the search strategy “Obesity” OR “abdominal obesity” OR “metabolic syndrome” OR “metabolic syndrome X” AND “epicardial fat”. Thirty-eight studies fulfilled the criteria. There was a highly significant (P<0.00001) correlation between EAT and body mass index (BMI), waist circumference (WC), or VAT. The correlation between EAT and VAT was significantly (P<0.0001) greater than the correlation between EAT and WC, which in turn was significantly greater than the correlation between EAT and BMI. Overall, EAT was 7.5±0.1 mm in thickness in the metabolic syndrome (n=427) compared to 4.0±0.1 mm in controls (n=301). EAT correlated significantly (P<0.0001) with SBP, TGs, HDL, and FBG, but the strength of the association was less than one-half of the relationship of EAT to indices of obesity. The results of multivariate analysis were less consistent but show a relationship between EAT and metabolic syndrome independent of BMI. In summary, the very strong correlation between EAT and VAT suggests a relationship between these two adipose tissue depots. Measurement of EAT can be useful to indicate VAT. Whereas EAT correlates significantly with each of the components of the metabolic syndrome— SBP, TGs, HDL, or FBG—the magnitude of the relationship is considerably and significantly less than the relationship of EAT to BMI. These data show the strong relationship between EAT and BMI but especially with WC and VAT. They also demonstrate the smaller magnitude of the association of EAT with standard coronary risk factors, related to the metabolic syndrome, and suggest that the unique features of this adipose tissue warrant detailed investigation.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Rabkin SW, Mathewson FA, Hsu PH. Relation of body weight to development of ischemic heart disease in a cohort of young North American men after a 26 year observation period: The Manitoba Study. Am J Cardiol 1977;39:452–458.
2.
Rabkin SW. Epicardial fat: Properties, function and relationship to obesity. Obes Rev 2007;8:253–261.
3.
Xu Y, Cheng X, Hong K, Huang C, et al. How to interpret epicardial adipose tissue as a cause of coronary artery disease: A meta-analysis. Coron Artery Dis 2012; 23:227–233.
4.
Bornfeldt KE, Tabas I. Insulin resistance, hyperglycemia, and atherosclerosis. Cell Metab 2011;14:575–585.
5.
Landsberg L, Aronne LJ, Beilin LJ, et al. Obesity-related hypertension: Pathogenesis, cardiovascular risk, and treatment: A position paper of The Obesity Society and the American Society of Hypertension. J Clin Hypertens 2013;15:14–33.
6.
Subramanian S, Chait A. Hypertriglyceridemia secondary to obesity and diabetes. Biochim Biophys Acta 2012;1821:819–825.
7.
Haas MJ, Mooradian AD. Regulation of high-density lipoprotein by inflammatory cytokines: Establishing links between immune dysfunction and cardiovascular disease. Diabetes Metab Res Rev 2010;26:90–99.
8.
Alberti KG, Eckel RH, Grundy SM, et al. International Diabetes Federation Task Force on Epidemiology and Prevention. Hational Heart and Blood Institute.American Heart Association.Wor L. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International. Circulation 2009;120:1640–1645.
9.
Grundy SM, Cleeman JI, Daniels SR, et al. American Heart Association. National Heart and Blood Institute L. Diagnosis and management of the metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation 2005;112:2735–2752.
10.
Mottillo S, Filion KB, Genest J, et al. The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis. J Am Coll Cardiol 2010;56:1113–1132.
11.
Galassi A, Reynolds K, He J. Metabolic syndrome and risk of cardiovascular disease: A meta-analysis. Am J Med 2006;119:812–819.
12.
Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008–2012.
13.
Moher D, Liberati A, Tetzlaff J, et al. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. J Clin Epidemiol 2009;62:1006–1012.
14.
Field AP. Meta-analysis of correlation coefficients: A Monte Carlo comparison of fixed- and random-effects methods. Psychol Methods 2001;6:161–180.
15.
Bettencourt N, Toschke AM, Leite D, et al. Epicardial adipose tissue is an independent predictor of coronary atherosclerotic burden. Int J Cardiol 2012;158:26–32.
16.
Kim M-K, Tanaka K, Kim M-J, et al. Epicardial fat tissue: Relationship with cardiorespiratory fitness in men. Med Sci Sports Exerc 2010;42:463–469.
17.
Lai Y-H, Yun C-H, Yang F-S, et al. Epicardial adipose tissue relating to anthropometrics, metabolic derangements and fatty liver disease independently contributes to serum high-sensitivity C-reactive protein beyond body fat composition: A study validated with computed tomography. J Am Soc Echocardiogr 2012;25:234–241.
18.
Gaborit B, Jacquier A, Kober F, et al. Effects of bariatric surgery on cardiac ectopic fat: Lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol 2012;60:1381–1389.
19.
Graner M, Siren R, Nyman K, et al. Cardiac steatosis associates with visceral obesity in nondiabetic obese men. J Clin Endocrinol Metab 2013;98:1189–1197.
20.
Borruel S, Fernandez-Duran E, Alpanes M, et al. Global adiposity and thickness of intraperitoneal and mesenteric adipose tissue depots are increased in women with polycystic ovary syndrome (PCOS). J Clin Endocrinol Metab 2013;98:1254–1263.
21.
Kilicaslan B, Ozdogan O, Aydin M, et al. Increased epicardial fat thickness is associated with cardiac functional changes in healthy women. Tohoku J Exp Med 2012;228:119–124.
22.
Cavalcante JL, Tamarappoo BK, Hachamovitch R, et al. Association of epicardial fat, hypertension, subclinical coronary artery disease, and metabolic syndrome with left ventricular diastolic dysfunction. Am J Cardiol 2012;110:1793–1798.
23.
Sironi AM, Petz R, De Marchi D, et al. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med 2012;29:622–627.
24.
Graner M, Seppala-Lindroos A, Rissanen A, et al. Epicardial fat, cardiac dimensions, and low-grade inflammation in young adult monozygotic twins discordant for obesity. American J Cardiol 2012;109:1295–1302.
25.
Gaborit B, Kober F, Jacquier A, et al. Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: Relationship to metabolic profile, cardiac function and visceral fat. Int J Obes 2012;36:422–430.
26.
Yerramasu A, Dey D, Venuraju S, et al. Increased volume of epicardial fat is an independent risk factor for accelerated progression of sub-clinical coronary atherosclerosis. Atherosclerosis 2012;220:223–230.
27.
Karadag B, Ozulu B, Ozturk FY, et al. Comparison of epicardial adipose tissue (EAT) thickness and anthropometric measurements in metabolic syndrome (MS) cases above and under the age of 65. Arch Gerontol Geriatr 2011;52:e79–e84.
28.
Iacobellis G, Lonn E, Lamy A, et al. Epicardial fat thickness and coronary artery disease correlate independently of obesity. Int J Cardiol 2011;146:452–454.
29.
Sicari R, Sironi AM, Petz R, et al. Pericardial rather than epicardial fat is a cardiometabolic risk marker: An MRI vs echo study. J Am Soc Echocardiogr 2011;24:1156–1162.
30.
Malavazos AE, Di Leo G, Secchi F, et al. Relation of echocardiographic epicardial fat thickness and myocardial fat. Am J Cardiol 2010;105:1831–1835.
31.
Aydin H, Toprak A, Deyneli O, et al. Epicardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome. Metab Syndr Relat Disord 2010;8:229–234.
32.
Wang TD, Lee WJ, Shih FY, et al. Relations of epicardial adipose tissue measured by multidetector computed tomography to components of the metabolic syndrome are region-specific and independent of anthropometric indexes and intraabdominal visceral fat. J Clin Endocrinol Metab 2009;94:662–669.
33.
Okyay K, Balcioglu AS, Tavil Y, et al. A relationship between echocardiographic subepicardial adipose tissue and metabolic syndrome. Int J Cardiovasc Imaging 2008;24:577–583.
34.
Iacobellis G, Pellicelli AM, Grisorio B, et al. Relation of epicardial fat and alanine aminotransferase in subjects with increased visceral fat. Obesity (Silver Spring) 2008;16:179–183.
35.
Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005;90:6300–6302.
36.
Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: A new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003;88:5163–5168.
37.
Nakazato R, Rajani R, Cheng VY, et al. Weight change modulates epicardial fat burden: A 4-year serial study with non-contrast computed tomography. Atherosclerosis 2012;220:139–144.
38.
Fu C-P, Sheu WH-H, Lee I-T, et al. Effects of weight loss on epicardial adipose tissue thickness and its relationship between serum soluble CD40 ligand levels in obese men. Clin Chim Act 2013;421:98–103.
39.
Sironi AM, Petz R, De Marchi D, et al. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med 2012;29:622–627.
40.
Gaborit B, Jacquier A, Kober F, et al. Effects of bariatric surgery on cardiac ectopic fat: Lesser decrease in epicardial fat compared to visceral fat loss and no change in myocardial triglyceride content. J Am Coll Cardiol 2012;60:1381–1389.
41.
Stramaglia G, Greco A, Guglielmi G, et al. Echocardiography and dual-energy x-ray absorptiometry in the elderly patients with metabolic syndrome: A comparison of two different tecniques to evaluate visceral fat distribution. J NutrHealth Aging 2010;14:6–10.
42.
Malavazos AE, Ermetici F, Cereda E, et al. Epicardial fat thickness: Relationship with plasma visfatin and plasminogen activator inhibitor-1 levels in visceral obesity. Nutr Metab Cardiovasc Dis 2008;18:523–530.
43.
Alberti KG, Zimmet P, Shaw J. IDF Epidemiology Task Force Consensus G. The metabolic syndrome—a new worldwide definition. Lancet 2005;366:1059–1062.
44.
Yorgun H, Canpolat U, Hazirolan T, et al. Increased epicardial fat tissue is a marker of metabolic syndrome in adult patients. Int J Cardiol 2013;165:308–313.
45.
Sengul C, Duman D. The association of epicardial fat thickness with blunted heart rate recovery in patients with metabolic syndrome. Tohoku J Exp Med 2011;224:257–262.
46.
Pierdomenico SD, Pierdomenico AM, Neri M, et al. Epicardial adipose tissue and metabolic syndrome in hypertensive patients with normal body weight and waist circumference. Am J Hypertens 2011;24:1145–1149.
47.
Iacobellis G, Willens HJ, Barbaro G, et al. Threshold values of high-risk echocardiographic epicardial fat thickness. Obesity (Silver Spring) 2008;16:887–892.
48.
Tok D, Cagli K, Kadife I, et al. Impaired coronary flow reserve is associated with increased echocardiographic epicardial fat thickness in metabolic syndrome patients. Coron Artery Dis 2013;24:191–195.
49.
Liang KW, Tsai IC, Lee WJ, et al. MRI measured epicardial adipose tissue thickness at the right AV groove differentiates inflammatory status in obese men with metabolic syndrome. Obesity 2012;20:525–532.
50.
Wang CP, Hsu HL, Hung WC, et al. Increased epicardial adipose tissue (EAT) volume in type 2 diabetes mellitus and association with metabolic syndrome and severity of coronary atherosclerosis. Clin Eendocrinol 2009;70:876–882.
51.
Okyay K, Balcioglu AS, Tavil Y, et al. A relationship between echocardiographic subepicardial adipose tissue and metabolic syndrome. Int J Cardiovasc Imaging 2008;24:577–583.
52.
Kerr JD, Holden RM, Morton AR, et al. Associations of epicardial fat with coronary calcification, insulin resistance, inflammation, and fibroblast growth factor-23 in stage 3–5 chronic kidney disease. BMC Nephrol 2013;14:26–30.
53.
De Vos AM, Prokop M, Roos CJ, et al. Peri-coronary epicardial adipose tissue is related to cardiovascular risk factors and coronary artery calcification in post-menopausal women. Eur Heart J 2008;29:777–783.
54.
Willens HJ, Byers P, Chirinos JA, et al. Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol 2007;99:1242–1245.
55.
Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: Structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989;94:225–232.
56.
Despres J-P. Body fat distribution and risk of cardiovascular disease: An update. Circulation 2012;126:1301–1313.
57.
Juni P, Holenstein F, Sterne J, et al. Direction and impact of language bias in meta-analyses of controlled trials: Empirical study. Int J Epidemiol 2002;31:115–123.
58.
Marwan M, Achenbach S. Quantification of epicardial fat by computed tomography: Why, when and how? J Cardiovasc Comput Tomogr 2013;7:3–10.
59.
Nakazato R, Rajani R, Cheng VY, et al. Weight change modulates epicardial fat burden: A 4-year serial study with non-contrast computed tomography. Atherosclerosis. 2012;220:139–144.
60.
Thanassoulis G, Massaro JM, Hoffmann U, et al. Prevalence, distribution, and risk factor correlates of high pericardial and intrathoracic fat depots in the Framingham heart study. Circ Cardiovasc Imaging 2010;3:559–566.
61.
Ding J, Hsu FC, Harris TB, et al. The association of pericardial fat with incident coronary heart disease: The Multi-Ethnic Study of Atherosclerosis (MESA). Am J Clin Nutr 2009;90:499–504.
62.
Mazzoccoli G, Dagostino MP, Fontana A, et al. Influence of the Gly1057Asp variant of the insulin receptor substrate 2 (IRS2) on insulin resistance and relationship with epicardial fat thickness in the elderly. Exp Gerontol 2012;47:988–993.
63.
Shemirani H, Khoshavi M. Correlation of echocardiographic epicardial fat thickness with severity of coronary artery disease-an observational study. Anadolu Kardiyol Derg 2012;12:200–205.
64.
Gorter PM, van Lindert AS, de Vos AM, et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008;197:896–903.
Information & Authors
Information
Published In
Metabolic Syndrome and Related Disorders
Volume 12 • Issue Number 1 • February 2014
Pages: 31 - 42
PubMed: 24219127
Copyright
Copyright 2014, Mary Ann Liebert, Inc.
History
Published in print: February 2014
Published online: 15 January 2014
Published ahead of print: 12 November 2013
Topics
Authors
Author Disclosure Statement
The author declares no conflicts of interest.
Metrics & Citations
Metrics
Citations
Export Citation
Export citation
Select the format you want to export the citations of this publication.
View Options
Get Access
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.⚠ Society Access
If you are a member of a society that has access to this content please log in via your society website and then return to this publication.